The latest price target for DexCom (NASDAQ:DXCM) was reported by Canaccord Genuity on February 14, 2025. The analyst firm set a price target for $103.00 expecting DXCM to rise to within 12 months (a possible 16.02% upside). 39 analyst firms have reported ratings in the last year.

The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Canaccord Genuity, and DexCom maintained their buy rating.

The last upgrade for DexCom Inc happened on February 3, 2025 when Redburn Atlantic raised their price target to $115. Redburn Atlantic previously had a neutral for DexCom Inc.

The last downgrade for DexCom Inc happened on July 26, 2024 when Baird changed their price target from $161 to $80 for DexCom Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.

While ratings are subjective and will change, the latest DexCom (DXCM) rating was a maintained with a price target of $99.00 to $103.00. The current price DexCom (DXCM) is trading at is $88.78, which is out of the analyst’s predicted range.